ReviewJournal of computer-aided molecular design2026
The (r)evolution of chemical space and molecular modeling: a time-resolved perspective.
Review in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The number and types of chemical compounds are expanding at an unprecedented rate. To model existing chemicals and aid in the design of novel chemical structures, appropriate computational approaches, tailored to the goals of specific projects, have evolved over time. This review analyzes the expansion of "chemical space" by tracing the historical milestones that have shaped molecular modeling from its inception to the present day. Utilizing data from public compound databases and a systematic bibliometric analysis of peer-reviewed literature, including specialized sources like the Journal of Computer-Aided Molecular Design, we mapped the co-evolution of chemical data and the algorithms designed to process it. While drug discovery has historically been the primary driver of this growth, our discussion extends to other domains, including macromolecular structural space. Due to the nature of public data, this analysis focuses mostly on open-access repositories with a few mentions of proprietary industrial libraries. By examining the trends in publications, this article provides a perspective on the current state of the field and the future trajectories of molecular modeling in an era of big data and artificial intelligence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.